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A B S T R A C T
Lamins are type V intermediate filament proteins that are located beneath the inner nuclear membrane. In
mammalian somatic cells, LMNB1 and LMNB2 encode somatic lamins B1 and B2, respectively, and the LMNA
gene is alternatively spliced to generate somatic lamins A and C.
Mutations in lamin genes have been linked to many human hereditary diseases, including neurodegenerative
disorders. Knowledge about lamins in the nervous system has been accumulated recently, but a precise analysis
of lamin subtypes in glial cells has not yet been reported. In this study we investigated the composition of lamin
subtypes in neurons, astrocytes, oligodendrocyte-lineage cells, and microglia in the adult rat cerebral cortex
using an immunohistochemical staining method. Lamin A was not observed in neurons and glial cells. Lamin C
was observed in astrocytes, mature oligodendrocytes and neurons, but not observed in oligodendrocyte pro-
genitor cells. Microglia also did not stain positive for lamin C which differed from macrophages, with lamin C
positive. Lamin B1 and B2 were observed in all glial cells and neurons. Lamin B1 was intensely positive in
oligodendrocyte progenitor cells compared with other glial cells and neurons. Lamin B2 was weakly positive in
all glial cells compared to neurons. Our current study might provide useful information to reveal how the onset
mechanisms of human neurodegenerative diseases are associated with mutations in genes for nuclear lamin
proteins.
Introduction
Nuclear lamins are type V intermediate filament proteins in the
nucleus that form a nuclear lamina, which is a filamentous or mesh-
work structure underlying the inner nuclear membrane (Burke and
Stewart, 2013; Zuela et al., 2012). Lamins were originally identified as
lamins A, B, and C (Gerace and Blobel, 1980). Lamins A and C, as well
as two other variants, AD10 and sperm-specific C2, are classified as A-
type lamins and are encoded by the LMNA gene, which produces each
specific subtype through alternative splicing. Three different B-type
lamin proteins are encoded by two genes (B1 by LMNB1 and B2 and
sperm-specific B3 by LMNB2). The nuclear lamina associates with other
nuclear envelope proteins and plays numerous roles, including main-
taining the nuclear shape and structure, assembly and disassembly of
the nucleus, heterochromatin organization, transcriptional regulation,
and other nuclear functions (Burke and Stewart, 2013; Zuela et al.,
2012; Simon and Wilson, 2013). Gene mutations for lamins and lamin-
associated proteins can cause diverse human diseases called “lamino-
pathies” or “nuclear envelopathies”, such as cardiac and muscular
dystrophy, lipodystrophy, and premature ageing disorder (Schreiber
and Kennedy, 2013).
Previous studies revealed that B-type lamins are expressed in most
or all cell types, whereas A-type lamins are not expressed in immature
cells during early developmental stages in mice (Röber et al., 1989;
Burke and Stewart, 2013; Zuela et al., 2012). In adult tissues, lamin A/C
is not expressed in immature cells but is observed in fully differentiated
cells, while lamin B1 is expressed abundantly in immature cells when
compared with differentiated cells in some types of epithelia and other
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tissues. Lamin B2 is ubiquitously expressed when compared with lamin
A/C and B1. These reports suggest that the expression of each lamin
subtype is regulated in tissue-specific, as well as cell-type specific
manners. (Broers et al., 1997; Coates et al., 1996; Willis et al., 2008;
Takamori et al., 2007).
Lamins in the nervous system and in other tissues have been in-
vestigated recently. A unique mutation in the LMNA gene leads to au-
tosomal recessive axonal Charcot-Marie-Tooth disease type 2B, which is
characterized by the loss of peripheral nerve myelination associated
with wasting and weakness in all four limbs ((Schreiber and Kennedy,
2013; De Sandre-Giovannoli et al., 2002; Tazir et al., 2013). Duplica-
tion of the LMNB1 gene, which causes increased expression of lamin B1,
is associated with autosomal dominant leukodystrophy (ADLD), a rare
adult-onset disease characterized by progressive myelin loss in the
central nervous system (Burke and Stewart, 2013; Padiath et al., 2006;
Zuela et al., 2012). Analysis of an in vitro culture system and transgenic
mice revealed that overexpression of lamin B1 in cells of the oligo-
dendrocyte cellular lineage suppresses differentiation and myelin for-
mation and that microRNA-23 (miR-23), an abundant miRNA in oli-
godendrocytes, represses the expression of lamin B1 and leads to
increased myelination and enhanced oligodendrocyte differentiation
(Lin and Fu, 2009; Heng et al., 2013; Lin et al., 2013, 2014). A series of
experiments using transgenic mice revealed that knockout or partial
deletion of lamin B1, B2 or both in the brain results in improper brain
development with abnormalities of nuclear shape, spindle apparatus
orientation, cell cycle regulation and neuronal migration (Vergnes
et al., 2004; Coffinier et al., 2010, 2011; Jung et al., 2013; Lee et al.,
2014). In the brain, lamin C encoded by LMNA gene is a major A-type
lamin, and the levels of lamin A mRNA are regulated specifically by
brain-specific microRNA miR-9 (Jung et al., 2012, 2014; Zuela et al.,
2012).
As lamins are predominantly localized to the inner nuclear mem-
brane, we used an anti-lamin B1 antibody as a nuclear membrane
marker combined with BrdU labelling to determine the positions of the
cell nuclei in oligodendrocytes and neurons in the rat cerebral cortex
(Kataoka et al., 2006; Tamura et al., 2007). Immunoreactivity for lamin
A/C was diminished during adult neurogenesis, and lamin B1 was in-
creased transiently in neuronal progenitor cells that were positive for
PSA-NCAM and doublecortin and were localized in two neurogenic
regions of the mammalian brain, namely, the subventricular zone of the
lateral ventricle and the subgranular zone of the dentate gyrus
(Takamori et al., 2007, 2014). All neurons in the adult rat retina were
positive for lamin B1 and B2, while some kinds of retinal neurons were
negative for lamin A, and photoreceptor cells were negative for lamin A
and C (Wakabayashi et al., 2011). However, many types of glial cells
are distributed in the brain, and detailed analyses of lamin subtypes in
each glial cell type are not yet reported. The analysis of cell-type spe-
cific expression of lamin subtypes in the glial cells may help in under-
standing the functional differences of lamin subtypes, as well as in
understanding the pathogenesis of nuclear lamina-associated neurode-
generative diseases.
We previously noticed that most cell nuclei in the brain parenchyma
stained with antibodies recognizing both lamin A and C but were not
stained with an anti-lamin A-specific antibody. We speculated that most
cells in the brain only express lamin C and not lamin A. However,
immunostaining using anti-lamin antibodies was not stable in for-
maldehyde fixation, and use of anti-lamin antibodies was only possible
in methanol-acetone fixation, which made detailed im-
munohistochemical analysis using antibodies against lamin-subtypes
and cell-type specific marker proteins quite difficult.
In this study, we have investigated the composition of lamin sub-
types in neurons, astrocytes, oligodendrocyte-lineage cells, and micro-
glia in the adult rat cerebral cortex. We improved and performed
multiple immunostaining analyses by using antibodies against each
lamin subtype and cell-type specific marker proteins through use of a
confocal laser microscope.
Methods
Animals
Adult male Wistar/ST rats (8 weeks old; Nippon SLC, Hamamatsu,
Japan) were purchased from Shimizu Laboratory Supplies (Kyoto,
Japan) and used for all experiments. The Animal Ethics Committee of
Kansai Medical University approved all experimental protocols, and all
studies were performed in accordance with the Principles of Laboratory
Animal Care (NIH publication No. 85-23, revised 1985)
Tissue preparation
The animals were anaesthetized by intraperitoneal injection with a
mixture of medetomidine (0.375mg/kg), midazolam (2mg/kg) and
butorphanol (2.5mg/kg) in phosphate-buffered saline (PBS). We used
three different fixation procedures based on the immunohistochemical
conditions recommended for each primary antibody. To perform im-
munohistochemistry for lamin A, C and B2, animals were transcardially
perfused with 0.1M PBS at pH 7.4 under deep anaesthesia, followed by
a fixative containing 4% formaldehyde and 0.2% picric acid in 0.1M
phosphate buffer (pH 7.4). The brains were dissected and post-fixed for
24 h in the same fixative at 4 °C. After fixation, brains were cryopro-
tected in 10% sucrose solution (in 0.1M phosphate buffer, pH 7.4) for
24 h followed by incubation in 20% sucrose solution (in 0.1M phos-
phate buffer, pH 7.4) for 24 h. For cryosectioning, fixed brain tissues
were embedded in Tissue-Tek O.C.T. compound (Sakura Finetek Japan,
Tokyo, Japan) and snap-frozen with dry ice. Coronal sections (30 μm
thickness) were obtained with a cryostat. These sections were stored at
4 °C in PBS and used for free-floating immunohistochemistry. For an-
tigen retrieval, fixed sections were boiled in 10mM sodium citrate
buffer (pH 6.0) for 30min. To perform immunohistochemistry for lamin
B1, fixative containing 1% formaldehyde and 0.05% picric acid in 0.1M
phosphate buffer (pH 7.4) was used for mild formaldehyde fixation.
Antigen retrieval was not performed in this condition. Methanol and
acetone fixation were performed using our previous protocol (Takamori
et all., 1997). The animals were sacrificed by cervical dislocation under
deep anaesthesia. The brains were dissected and snap-frozen with CO2
gas. Coronal sections at a 10 μm thickness were cut using a cryostat,
collected on glass slides and air-dried at room temperature for 1 h.
Subsequently, the sections were fixed in cold methanol at −20 °C for
10min, followed by three dips in acetone at 4 °C (5 s each) and air-dried
for 5min.
Immunohistochemistry
Immunohistochemistry was performed on tissues from a total of 18
rats fixed with three different fixation methods as mentioned above.
Brain coronal sections were obtained by free-floating sections from
positions at approximately bregma −1.5mm to bregma +4.5mm
(Paxinos and Watson, 1986). Ten sections per animal were chosen for
immunohistochemistry. Primary antibodies used are summarized in
Table 1. Free-floating sections were incubated with primary antibodies
in PBST (PBS with 0.03% Triton X-100) at 4 °C for 24 h. Then, sections
then were rinsed in PBST two times for 15min at room temperature and
incubated with Cy2-, Cy3- or Cy5-labelled donkey secondary antibodies
specific to the appropriate animal species (Jackson Immuno-Research,
West Grove, PA, USA; 1:200) in PBST at 4 °C for 3 h. Alexa Fluor 488-,
and 555-labelled donkey secondary antibodies (1:400, Invitrogen/Mo-
lecular Probes, Carlsbad, CA, USA) were used in some cases. Sections
were rinsed in PBST two times and then mounted with a medium
containing 100mM DTT, 5 μg/ml Hoechst dye 33258 (Nacalai Tesuque
Inc., Kyoto, Japan), and 50% glycerol in PBS at pH 7.4. Some sections
were counterstained with TOPRO-3 (Molecular Probes, Eugene, OR,
USA; 1:1000) for nucleic acid detection. Fluorescently immunostained
sections were observed and photographed with a confocal laser
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microscope (model LSM510-META; Carl Zeiss, Oberkochen, Germany).
The fluorescent signal intensity was measured with an imaging browser
for micrographs (ZEN, Carl Zeiss, RRID:SCR_013672). The area from
cortical layer II to layer V in the parietal and temporal lobes of the
cerebral cortex of the 10 chosen sections was examined with a confocal
laser microscope (LSM 510, Carl Zeiss). Fluorescent images were ac-
quired as single optical sections at 1-μm intervals to detect the borders
of the nucleus and cytosol clearly, which allowed identification of the
cell-specific expression of lamin. The goat polyclonal anti-lamin B1
antibody (Santa Cruz Biotechnology) recognizes lamin B1 from extracts
of primary mouse embryonic fibroblasts but does not recognize lamin
B2 or mutant lamin B1 fused to beta-geo, which lacks 273 amino acids
at its carboxy-terminus (Vergnes et al., 2004). Therefore, we used this
antibody as an anti-lamin B1 antibody as previously reported (Vergnes
et al., 2004; Takamori et al., 2007, 2014). Specificity of other anti-
lamin antibodies had already been confirmed by two-dimensional im-
munoblotting in previous studies (Machiels et al., 1995; Lehner et al.,
1986), as well as Western blot analysis and peptide neutralization ex-
periments in our previous studies (Wakabayashi et al., 2011). The
original TIFF files were imported into Photoshop software (Adobe
Systems, San Jose, CA, USA) to prepare the images for publication; all
images were processed, adjusted for brightness and contrast, and re-
sized to 300 dpi using this application. The level of immunoreactivity
observed is indicated as follows for all results: (++) = highly positive;
(+) = positive; (–) = negative (Table 2).
Results
Glial cells and neurons in the cerebral cortex did not express lamin A
We used antibodies against lamin A and C that are specific to their
C-termini to distinguish these two splicing variants. Sections of cortex
were stained with a rabbit anti-lamin A antibody (L1293) provided by
Sigma-Aldrich Co. and for several cell-type specific markers (Fig. 1).
Specimens were fixed using 4% formaldehyde combined with heat
treatment. Lamin A was not observed in any of the cells in the cerebral
cortex except for capillary wall cells including vascular endothelial cells
and pericytes, which were nestin-positive and demonstrated squamous
epithelial morphology using brightfield microscopy that were positive
for nestin (Fig. 1A–D, large arrowheads, and Fig. 1E–H, small arrow-
heads). Astrocytes were recognized with positive staining for glial fi-
brillary acidic protein (GFAP) (Fig. 1A–H, large arrowhead in E–H) and
mature oligodendrocytes were recognized with GST-pi, which is a
marker for mature oligodendrocytes (Tansey and Cammer, 1991) and
Olig2, which serves as a marker of oligodendrocyte progenitor cells and
mature oligodendrocytes (Zhou et al., 2000) (Fig. 1I–P, large arrow-
heads). Both glial cell types were lamin A-negative. Immature oligo-
dendrocytes that were recognized with only Olig2+ staining were also
negative for lamin A (Fig. 1M–P, small arrowhead). Lamin A was not
observed in microglia, which were identified as being positive for io-
nized calcium binding adaptor molecule 1 (Iba1) (Fig. 1Q–T, large ar-
rowheads), but observed in capillary wall cells, which were vimentin-
positive (Fig. 1Q–T, small arrowheads). Iba-1 positive macrophages in
the meninges were positive for lamin A (Fig. 1U–X, a small arrowhead),
compared with Iba1 positive microglia in cortex (Fig. 1U–X, large ar-
rowhead). DNA in neurons was diffusely stained by Hoechst 33258
when compared with other cells (Fig. 2I–L). Therefore, neurons that
were stained with a diffuse nuclear stain were concluded to be negative
for lamin A (Fig. 1A–T). We confirmed the specificity of the lamin A
antibody used for multistaining by using another lamin A antibody
(Millopore, MAB 3540, clone 133A2), which showed specific staining
with methanol-acetone fixation (Takamori et al., 2007). Both lamin A
antibodies showed identical staining patterns in the cortex (data not
shown). All analysed areas showed that neural cells were negative for
Table 1
List of antibodies used as marker.
Antibody Immunogen Manufacture and catalog number,
clone
Species Dilution Cell type specificity
CD68 Rat spleen cells
(Dijkstra et al., 1985)
BMA Biomedicals AG, Augst,
Switzerland,　T-3003, clone ED1
Mouse monoclonal
IgG1
1/100 macrophage
GFAP GFAP from pig spinal cord
(Debus et al., 1983)
Sigma-Aldrich, St. Louis, MO,
G3893, clone G-A-5
Mouse monoclonal
IgG1
1/200 astrocyte
GFAP GFAP from human brain Sigma-Aldrich, G9269 Rabbit polyclonal 1/200 astrocyte
GFAP GFAP from cow spinal cord Dako-Japan, Kyoto, Japan, Z0334 Rabbit polyclonal 1/200 astrocyte
GST-pi Human (GST)-pi, 5-210aa. BD Pharmingen, San Diedo, CA,
USA, 610718, clone 3/GST-pi
Mouse monoclonal
IgG1
1/200 oligodendrocyte (mature)
Iba1 Iba1 (human, mouse, rat),
C-terminus
Wako Pure Chemical Industries,
Osaka, Japan. No. 019-19741
Rabbit polyclonal 1/200 microglia/
macrophage
Iba1 Human Iba1, 135-147aa. Abcam plc, Cambridge, UK, ab5076 Goat polyclonal 1/100 microglia/
macrophage
NG2 Cell line expressing
a truncated form of NG2 chondroitin sulfate proteoglycan
Millipore Bioscience Research
Reagents,
Temecula, CA.
Mab5384, clone 132.39
Mouse monoclonal
IgG1
1/100 oligodendrocyte (immature)
Nestin Rat nestin, 544-776 aa. R&D systems Inc, Minneapolis, MN,
USA,
AF2736
Goat polyclonal 1/200 blood cell
NeuN Purified cell nuclei from mouse brain (Mullen et al., 1992).
This antibody recognizes Fox-3/Rbfox-3 preferentially (Kim
et al., 2009)
Millipore Bioscience Research
Reagents,
MAB377, clone A60
Mouse monoclonal
IgG1
1/100 neuron
OLIG2 Mouse OLIG2, C-terminus Santa Cruz Biotechnology, Santa
Cruz, USA, sc-19969, C-17
Goat polyclonal 1/100 oligodendrocytes (immature/
mature)
RECA-1 Stromal cells from rat lymph node (Duijvestijn et al., 1992) Serotec, MCA970R, clone HIS52 Mouse monoclonal
IgG1
1/200 blood cell
RIP Rat olfactory bulb extract
(Friedman et al., 1989). This antibody recognize 2,3′-cyclic
nucleotide 3′-phosphodiesterase preferentially
(Watanabe et al., 2006)
Millipore Bioscience Research
Reagents,
MAB1580, clone NS-1
Mouse monoclonal
IgG1
1/1000 oligodendrocyte (mature)
Vimentin Vimentin purified from pig eye lens (Osborn et al., 1984) Sigma-Aldrich, V6389, clone V9 Mouse monoclonal
IgG1
1/100 blood cell/
meningeal cell
GFAP: Glial fibrillary acidic protein, GST-pi :glutathione-S-transferase-pi.
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lamin A (Fig. 1A–D). Representative data are shown in Fig. 1 and the
signal intensity of the represented images was shown in supplemental
Fig. 1. There was no lamin A signal intensity in astrocytes (Fig. S1a,
white arrow/bracket), mature oligodendrocytes (Fig. S1b, white allow/
bracket) and microglia (Fig. S1c, a white arrow/bracket), compared
with the intensity of lamin A-positive cells, such as capillary wall cells
(Fig. S1a–c, yellow arrows/brackets) in the same field, which were
analysed using the same microscopy imaging settings and conditions.
Macrophages inside the meninges (Fig. S1d, yellow arrow/bracket)
showed a lamin A-positive signal compared with microglia in the same
field (Fig. S1d, white arrow/bracket). Taken together, we identified
that neuron and glial cells were negative for lamin A.
Neurons, astrocytes and mature oligodendrocytes express lamin C
Sections were stained with rabbit anti-lamin C antibody and several
cell-type specific markers to investigate the distribution of lamin C in
neurons and glial cells in the cerebral cortex. Specimens were fixed using
4% formaldehyde combined with heat treatment. Lamin C was weakly
positive in GFAP-positive astrocytes (Fig. 2A–D, large arrowheads) when
compared with neurons (Fig. 2A–D, small arrowheads). Neurons were
detected with TOPRO-3, a fluorescent dye for nucleic acid detection (Shao
et al., 2011). In the cortex, TOPRO-3 stained cell nuclei and the cytoplasm
of neurons (Figs. 2A–D, 3A–D, 4A–D small arrowheads) which were further
recognized with a large nucleus size with diffuse irregular staining by
Hoechst 33258 compared to glial cells which demonstrate small, compact
and intense staining (Figs. 2A–D, 3A–D, 4A–D, large arrowheads,
Matamales et al., 2009). Lamin C was observed in mature oligoden-
drocytes, which were intensely positive for GST-pi and positive for Olig2
(Fig. 2E–H, small arrowheads) but was not observed in immature oligo-
dendrocyte progenitor cells, which were weakly positive for GST-pi and
intensely positive for Olig2 (Fig. 2E–H, large arrowheads). In the cortex,
lamin C was not observed in microglia, which were Iba-1-positive
(Fig. 2I–L, large arrowheads), and differed from neurons, which were
NeuN-positive (Fig. 2I–L, small arrowheads). However, lamin C was ob-
served in macrophages, which reside in the meninges and were positive for
Iba-1 (large arrowheads) (Fig. 2M–P). The staining patterns of the anti-
lamin A/C antibody, which is expected to recognize both lamin A and C,
purchased from Chemicon (MAB 3538, clone 131C3), and used in our
previous study (Takamori et al., 2007), were like those seen using the anti-
lamin C specific antibody, but not the anti-lamin A specific antibody in this
study. The staining patterns shown by the anti-lamin A/C antibody in the
brain might originate from lamin C (data not shown). All analysed areas
showed that astrocytes, mature oligodendrocytes and neurons possessed
lamin C. Representative data are shown in Fig. 2 and the signal intensity of
represented images is shown in supplemental Fig. 2. Lamin C signal in-
tensity was increased in neurons (Fig. S2a, white arrow/bracket) and as-
trocytes (Fig. S2a, yellow arrow/bracket) that were lamin C-positive. The
intensity of lamin C in neurons was higher than that observed in astrocytes
(Fig. S2a). The intensity of lamin C in mature oligodendrocytes (Fig. S2b,
white arrow/bracket, Olig2+/GST-pi+high) was high, while immature
oligodendrocytes (Fig. S2b, yellow arrow/bracket, Olig2+/GST-pi+
significantly low) did not show any lamin C signal. Microglia did not show
any lamin C signal intensity (Fig. S2c, white arrow/bracket), compared
with neurons which showed high lamin C intensities (Fig. S2c, yellow
arrow/bracket). Macrophages in the meninges (Fig. S2d, white arrows/
brackets) showed a lamin C-positive signal.
Lamin B1 is detected in all glial cells and neurons, especially in
oligodendrocyte progenitor cells
Sections of the cortex were stained with goat anti-lamin B1 antibody
and several cell-type specific markers. Specimens were fixed using 1%
formaldehyde. Lamin B1 was observed in astrocytes, which were GFAP-
positive (Fig. 3A–D, large arrowheads), as well as in neurons
(Fig. 3A–D, small arrowheads); neuron cytoplasm and nuclei are
stained with TOPRO-3. Next, we examined lamin B1 expression in the
oligodendrocyte lineage (Fig. 3E–H). Lamin B1 was intensely positive in
oligodendrocyte progenitor cells, which were NG2-positive and RIP-
negative (Fig. 3E–H, large arrowheads), compared with mature oligo-
dendrocytes, which were RIP-positive and NG2-negative (Fig. 3E–H,
small arrowheads). Lamin B1 was observed in microglia, which were
Iba-1-positive (large arrowheads) (Fig. 3I–L). Capillary wall cells, which
were RECA-1-positive, were also positive for lamin B1 (Fig. 3I–L, small
arrowheads). Lamin B1 was observed in meningeal macrophages,
which were positive both for Iba-1 and CD68 (Fig. 3M–P, small ar-
rowheads), and was observed in microglia, which were Iba-1-positive
and CD68-negative (Fig. 3M–P, large arrowheads). Another monoclonal
anti-lamin B1 antibody provided by Merck Millipore (MAB 3213, clone
119D5-F1) showed similar staining patterns in the methanol-acetone
fixed brains, as lamin B1-intensely positive cells were localized to the
cortex (data not shown, Takamori et al., 2007). All analysed areas
showed that neural cells possessed lamin B1. Representative data are
shown in Fig. 3 and the signal intensity of represented images is shown
in supplemental Fig. 3. Lamin B1 signal intensities in neurons (Fig. S3a,
a yellow arrow/bracket) and astrocytes (Fig. S3a, white arrow/bracket)
were similar. The intensity of lamin B1 staining in immature oligo-
dendrocytes (Fig. S3b, yellow arrows/brackets, NG2+/RIP-) was
higher than that observed in mature oligodendrocytes (Fig. S3b, white
arrow/bracket, NG2-/RIP+). Microglia (Fig. S3c, white allow/bracket)
also possessed lamin B1 signal intensity with similar levels of staining
to that observed in neurons (Fig. S3c, yellow arrow/bracket) identified
with dispersed nuclear staining and largely sized nuclei (Fig. 3I–L).
Although macrophages in both the meninges and microglia demon-
strated lamin B1 signals, the intensity observed in macrophages, which
reached the maximum with 250 intensity (Fig. S3d, white arrows/
brackets), was higher than that observed in microglia, which showed
intensity lower than 200 intensity (Fig. S3d, yellow arrow/bracket).
All glial cells and neurons in the cerebral cortex express lamin B2
Sections of the cortex were stained with a rabbit anti-lamin B2 an-
tibody and several cell-type specific markers. Specimens were fixed
using 4% formaldehyde combined with heat treatment. Lamin B2 was
observed in GFAP-positive astrocytes (Fig. 4A–D, large arrowheads),
but the staining intensity was weak when compared to that observed in
neurons; neurons were identified by cytoplasm and nuclei stained with
TOPRO-3 (Fig. 4A–D, small arrowheads). Next, we examined lamin B2
Table 2
List of lamin antibodies.
Antibody Immunogen Manufacture and catalog number Species Fixative Dilution
Lamin A Human lamin A, 598–611aa. Sigma-Aldrich, L1293 Rabbit polyclonal 4%FA-H 1/100
Lamin A Human lamin C, 598–611aa. Merck Millipore, MAB 3540, clone 133A2 Mouse monoclonal, IgG Mt-Ac 1/100
Lamin C Human lamin C, 565–572aa. Acris, Rockville, MD, USA, BP4505S Rabbit polyclonal 4%FA-H 1/100
Lamin B1 Rat lamin B1, whole molecule Merck Millipore, MAB 3213, clone 119D5-F1 Mouse monoclonal, IgG Mt-Ac 1/40
Lamin B1 Human lamin B1, C-terminus Santa Cruz Biotechnology, sc-6216, C-20 Goat polyclonal 1%FA 1/100
Lamin B2 Extracts from chicken nuclei Invitrogen Corporation/Zymed, Waltham, MA USA, 33-2100, clone E-3 Mouse monoclonal, IgG1κ 4%FA-H 1/100
1%FA: 1% formaldehyde, 4%FA-H: 4% formaldehyde combined with heat treatment (antigen retrieval), Mt-Ac: methanol-acetone.
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Fig. 1. Distribution of lamin A in the cerebral cortex. A–H, Sections were stained with antibodies against lamin A (magenta), GFAP (green) and nestin (blue). A–D,
Low-power field. Large arrowheads indicate lamin A-positive capillary wall cells. Twenty section images with 1-μm intervals were stacked by maximum projections.
E–H, Large arrowhead indicates an astrocyte. Small arrowheads indicate capillary wall cells. I–P, Sections were stained with antibodies against lamin A (magenta),
GST-pi (green) and olig2 (blue). I–L, Large arrowhead indicates mature GST-pi- and olig2-positive oligodendrocytes. Small arrowheads indicate capillary wall cells.
M–P, Large arrowhead indicates GST-pi- and olig2-positive mature oligodendrocyte. Small arrowheads indicate GST-pi-negative and olig2-positive oligodendrocyte
progenitor cells. Q–X, Sections were stained with antibodies against lamin A (magenta), Iba-1 (green), and vimentin (blue). Small arrowheads in Q–T indicate
capillary wall cells, light blue signal shows Iba-1 positive macrophages (small arrowheads in U–X). The meninges were identified using brightfield imaging and
shown with a white line bracket. Specimens were fixed using 4% formaldehyde combined with heat treatment. DNA was stained with Hoechst 33258 (cyan). Scale
bar, 40 μm in A–D, 20 μm in E–X. Images of single optical sections (E-X (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article).
Fig. 2. Distribution of lamin C in the cerebral cortex. A–D, Sections were stained with antibodies against lamin C (magenta) and GFAP (green) and counterstained
with TOPRO-3 for nucleic acid detection (blue). Large arrowheads indicate astrocytes. Small arrowheads indicate neurons; these are further indicated with cytoplasm
that is stained with TOPRO-3. E–H, Sections were stained with antibodies against GSTpi (green) and Olig2 (blue). Large arrowheads indicate an oligodendrocyte
progenitor cell. Small arrowheads indicate mature oligodendrocytes. I–L, Sections were stained with antibodies against Iba-1 (green) and NeuN (blue). Large
arrowheads indicate microglia. Small arrowheads indicate neurons. Note that microglia are negative for lamin C. M–P, Sections were stained with antibodies against
Iba-1 (green) and vimentin (blue). Large arrowheads indicate macrophages in the meninges. The meninges are indicated with a white line bracket. Specimens were
fixed using 4% formaldehyde combined with heat treatment. DNA was stained with Hoechst 33258 (cyan). Scale bar, 20 μm. Images of single optical sections (A–P)
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
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in the oligodendrocyte lineage (Fig. 4E–H). Lamin B2 was observed in
oligodendrocyte progenitor cells that were Olig2-positive and lamin C-
negative (Fig. 4E–H, large arrowheads), as well as in mature oligo-
dendrocytes, which were both Olig2- and lamin C-positive (Fig. 4E–H,
small arrowheads), as described above. Both staining intensities were
weak when compared with neurons (Fig. 4A–D and E–H). Lamin B2 was
observed in Iba-1-positive microglia (Fig. 4I–L, large arrowheads), but
staining intensity was weak when compared with neurons; these were
recognized with their cytoplasm and nuclei stained with TOPRO-3
(Fig. 4I–L, small arrowheads). Lamin B2 was observed in Iba-1-positive
meningeal macrophages (Fig. 4M–P, small arrowheads) and microglia
(Fig. 4M–P, large arrowheads). All analysed areas showed that neural
cells possessed lamin B2. Representative data are shown in Fig. 4 and
the signal intensity of represented images is shown in supplemental
Fig. 4. Lamin B2 signal intensity in neurons (Fig. S4a, yellow arrow/
bracket) was higher than that observed in astrocytes (Fig. S4a, white
arrow/bracket). The intensity of lamin B2 in mature (Fig. S4b, white
arrow/bracket) and immature oligodendrocytes (Fig. S4b, yellow
allow/bracket) were similar, whereas neurons (red arrowheads) had a
higher staining intensity in same field. Microglia also possessed lamin
B2 signal intensity (Fig. S4c, yellow arrow/bracket), but the signal in-
tensity was lower than that observed in neurons (Fig. S4c, white arrow/
bracket). Macrophages in the meninges and microglia in the cortex (Fig.
S4d, yellow/bracket and white arrow/bracket, respectively) possessed
lamin B2 signal (Fig. 4M–P), with similar staining intensities.
Fig. 3. Distribution of lamin B1 in the cerebral cortex. Sections were stained with antibodies against lamin B1 (magenta) and several cell-type specific markers. A–D,
Sections were fixed with 1% formaldehyde and stained with anti-GFAP antibody (green) and counterstained with TOPRO-3 for nucleic acid detection. Large
arrowheads indicate astrocytes. Small arrowheads indicate neurons; also indicated by cytoplasm that is stained with TOPRO-3. E–H, Sections were stained with
antibodies against NG2 (green) and RIP (blue). Large arrowheads indicate oligodendrocyte progenitor cells. Small arrowheads indicate mature oligodendrocytes. I–L,
Sections were stained with antibodies against Iba-1 (green) and RECA1 (blue). Large arrowheads indicate microglia. Small arrowheads indicate capillary wall cells.
M–P, Sections were stained with antibodies against Iba-1 (green) and CD68 (blue). Large arrowheads indicate microglia. Small arrowheads indicate macrophages in
the meninges. The meninges were identified using brightfield imaging and shown with a white line bracket. Scale bar, 20 μm. Images of single optical sections (A-P
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).
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Fig. 4. Distribution of lamin B2 in the cerebral cortex. Sections were stained with antibodies against lamin B2 (magenta) and several cell-type specific markers. A–D,
Sections were stained with anti-GFAP antibody (green) and counterstained with TOPRO-3 for nucleic acid detection. Large arrowheads indicate astrocytes. Small
arrowheads indicate neurons; also indicated by cytoplasm stained with TOPRO-3. E–H, Sections were stained with antibodies against Olig2 (green) and lamin C
(blue). Large arrowheads indicate an oligodendrocyte progenitor cell, which is negative for lamin C. Small arrowheads indicate mature oligodendrocytes. I–L,
Sections were stained with an anti-Iba-1 antibody (green) and were also counterstained with TOPRO-3 for nucleic acid detection. Large arrowheads indicate
microglia. Small arrowheads indicate a neuron; these are also indicated with cytoplasm that is stained with TOPRO-3. M–P, Sections were stained with an anti-Iba-1
antibody (green). Large arrowheads indicate microglia. Small arrowheads indicate a macrophage in the meninges. The meninges were identified under bright field
and shown with a white line bracket. Specimens were fixed using 4% formaldehyde combined with heat treatment. DNA was stained with Hoechst 33258 (cyan).
Scale bar, 20 μm. Images of single optical sections (A–P) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version
of this article).
Table 3
Level of lamina immunoreactivity.
OPC oligodendrocyte astrocyte neuron microglia macrophage
Lamin A − − − − − +
Lamin C − + + ++ − +
Lamin B1 ++ + + + + ++
Lamin B2 + + + ++ + +
++, highly positive; +, positive; −, negative.
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Discussion
In the present study, we investigated the constitution patterns for
lamin-subtypes in the neural cells of the adult rat cerebral cortex. The
results of lamin-subtype patterning were shown as presented in the
table (Table 3). Cortical glial cells, as well as neurons, contain lamin C
as a major A-type lamin compared with lamin A. Astrocytes and oli-
godendrocytes, both mature glial cells, showed similar staining patterns
with lamin A negative (Fig. 1A–P) and lamin C positive (Fig. 2A–H).
Microglia, which are also mature glial cells, showed different patterns
and lacking both lamin A (Fig. 1Q–X) and C (Fig. 2I–L). -Oligoden-
drocyte progenitor cells, which are in immature and proliferative states,
- show no lamin C immunoreactivity (Fig. 2E–H) and -intense lamin B1
immunoreactivity, compared with mature oligodendrocytes -
(Fig. 3E–H). The staining intensity of lamin B2 in all glial cells was
relatively weak compared with cortical neurons (Fig. 4). These data
indicate that glial cells in the adult cerebral cortex showed cell type
specific lamin expression patterns.
Fixation method is very important for detecting the appropriate
antibody specificity. In the present study, we performed multicolor
immunohistochemical analysis using antibodies against lamin subtypes
and cell-type specific marker proteins, which previously have been re-
ported to be specific for each cell type (Takamori et al., 2007). To
identify mature neurons, we used anti-NeuN antibody and a fluorescent
dye TOPRO-3, which stains nucleic acid dispersive. Methanol–acetone
fixation has been used for suitable staining to lamin. However, this
condition alters other epitopes of cell-type specific marker proteins and
causes problems with the antibody specific reaction (Senda et al., 2005;
Takamori et al., 2007; Wakabayashi et al., 2011). Here, we examined
the suitable fixative condition for multiple immunostainings for lamins
and cell-type specific marker proteins (Table 1). The staining was
performed with 4% formaldehyde fixation combined with heat treat-
ment for antibodies against lamins A, C, and B2 and with 1% for-
maldehyde fixation for an antibody against lamin B1.
The disease gene of adult-onset ADLD was reported to be localized
to chr. 5q23-q31, including gene lamin B1 duplication (Brussino et al.,
2009; Marklund et al., 2006; Meijer et al., 2008; Melberg et al., 2006).
Several clinical features show autonomic dysfunction, gait dis-
turbances, postural hypotension, urinary dysfunction and demyelina-
tion in CNS (Coffeen et al., 2000; Schwankhaus et al., 1994). CNS de-
myelination especially is the primary pathology of ADLD; however,
cellular abnormality has not been confirmed in histopathological ana-
lysis (Coffeen et al., 2000). Meanwhile, lamin B1 overexpression in
oligodendrocytes led to oligodendrocyte maturation arrest (Lin and Fu,
2009). Lamin B1 overexpression by transgenic mice with bacterial ar-
tificial chromosome clone spanning also showed cognitive abnormal-
ities, progressive motor impairment at 12 months of age and myelina-
tion defect at 24 months of age (Heng et al., 2013). Our data indicate
that the expression of lamin B1 was high in oligodendrocyte progenitor
cells, however, lamin B1 was repressed during oligodendrocyte differ-
entiation and lamin C was induced in mature oligodendrocytes in the
adult brain. This finding is consistent with the previous finding that
lamin B1 mRNA levels are downregulated during oligodendrocyte
maturation in cultured conditions (Dugas et al., 2006). The levels of
mRNA and protein of lamin B1 peaked at birth or postnatal day 1 and
gradually decreased from postnatal day 1 to 10 months of age (Lin
et al., 2009). Therefore, these data, including our results, strongly
suggest that lamin B1 regulates OPC proliferation and maintains the
immature condition (Fig. 3).
In our previous studies, in two neurogenic regions of the adult brain,
neuronal progenitor cells recognized by anti-PSA-NCAM and anti-dou-
blecortin antibodies were negative for lamin C and intensely positive
for lamin B1. However, mature neurons recognized by NeuN antibody
were positive for lamin C and weakly positive for lamin B1 (Takamori
et al., 2007, 2014). These results indicate that the expression of lamin C
is increased and lamin B1 is decreased during neuronal differentiation
from progenitor cells into neurons (Table 3). The alteration patterns for
lamin C and B1 during neuronal differentiation are similar to those in
oligodendrocyte differentiation. Conversely, the alteration pattern for
lamin B2 expression is different during the differentiation process in
oligodendrocytes and neurons. The lamin B2 is constantly expressed
throughout oligodendrocyte maturation; meanwhile, lamin B2 is ex-
pressed strongly in mature neurons compared with the neuronal pro-
genitor stage (Takamori et al., 2007). Therefore, lamin B2 might have
some specific function only in mature neurons. Lamin B1 and B2
knockout mice died shortly after birth and lacked the capacity for
neuronal migration and survival (Coffinier et al., 2010; Kim et al.,
2011). Each lamin B compensation experiment with reciprocal knock-in
mice could not fully compensate a loss of each lamin B during embryo
development (Lee et al., 2014), suggesting that B-type lamins have a
key role for neuronal development. Recently, brain tissue in Alzhei-
mer’s disease showed the reduction of lamin B protein level, suggesting
that lamin B disruption mediates neurodegeneration in tauopathies
(Frost, 2016). From these reports, B-type lamin expression in neurons is
indispensable for neurogenesis and neuron survival. In the same way,
lamin B2 expression in oligodendrocytes might have a role for main-
taining oligodendrocyte survival through continuously expressing B-
type lamins.
Microglia with small delineated processes actively screening the
intra neuronal space for incoming threats were negative for lamin C and
differed from astrocytes and oligodendrocytes (Fig. 2). Microglia are
related closely to macrophages, which originate from hematopoietic
stem cells and their origin is different from neuroectodermal-derived
astrocytes and oligodendrocytes in the brain (Prinz et al., 2014).
However, the meningeal macrophages, which were positive for Iba1
with round morphology and positive for lamin C, differed from mi-
croglia within the brain parenchyma (Fig. 2M–P). These data indicate
that microglia and macrophages have different lamin compositions
despite the related origin from hematopoietic cell lineage.
Lamin C only mice, which produce lamin C but not lamin A, display
as entirely healthy. Thus, lamin A might be dispensable in mice, al-
though the phenotype of a deficiency of both lamin A and lamin C
showed slow growth, muscle weakness, and death by 6 weeks of age.
(Fong et al., 2006). Meanwhile, mutation of LMNA causes multiple
human diseases including muscular dystrophy, cardiomyopathy, and
lipodystrophy (Worman et al., 2009). A few mutations of prelamin A,
which alter the structure of prelamin A, induces Hutchinson-Gilford
progeria syndrome (Eriksson et al., 2003; De Sandre-Giovannoli et al.,
2003). Two knock-in lines contained a 5-nucleotide mutation in the
miR-9 binding site in prelamin A 3’UTR, and replaced prelamin A
3’UTR with lamin C 3’UTR, induced large amounts of lamin A in the
brain, and pathological defects were detected mainly in capillary en-
dothelial cells. However, there was no obvious neuropathology or be-
havior disorder, which could explain the absence of abnormal pa-
thology in CNS (Jung et al., 2014). Our data, in which lamin A was not
observed in the neural cells in the cerebral cortex but was observed in
capillary wall cells, confirmed that lamin A might not be relate directly
to CNS, but there might be indirect relations via endothelial cells in the
brain parenchyma and meninges.
In summary, our study showed the composition of each lamin
subtype in the glial cells of adult brain using an immunohistochemical
procedure. Current information might be useful to understand the onset
mechanism of human neurodegenerative diseases associated with nu-
clear lamina proteins as well as functional differences of each lamin
subtypes.
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